Latest period
$354.00M
YoY change
-0.3%
5Y CAGR
+6.9%
Peak year (2024)
$380.00M
Cumulative CapEx
$1.93B
CapEx history chart for Solventum (SOLV) from 2020 to 2025
Latest: $379.00M
CapEx growth chart for Solventum (SOLV) from 2020 to 2025
Latest: -0.3%
CapEx history table for Solventum (SOLV) from 2020 to 2025
| 2025 | $379.00M | -0.3% | −$1.00M | ||
| 2024 | $380.00M | +31.0% | +$90.00M | ||
| 2023 | $290.00M | +15.5% | +$39.00M | ||
| 2022 | $251.00M | -9.4% | −$26.00M | ||
| 2021 | $277.00M | +2.2% | +$6.00M | ||
| 2020 | $271.00M | — | — |
- 2025$379.00M-0.3%
- 2024$380.00M+31.0%
- 2023$290.00M+15.5%
- 2022$251.00M-9.4%
- 2021$277.00M+2.2%
- 2020$271.00M—
CapEx values are taken from Solventum's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at Solventum (SOLV)
According to Solventum's latest reported financial statements, the company's current CapEx (TTM) is $354.00M. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Solventum (SOLV) reported CapEx of $379.00M – edged down 0.3% year-over-year.
Across 2020–2025 (5 years), Solventum CapEx produced a CAGR of +6.9% – with mixed annual results across the window.
Across the available history, CapEx reached its high of $380.00M in 2024 and its low of $251.00M in 2022.
Solventum Capital Expenditures by Year
Solventum Capital Expenditures 2025: $379.00M
In 2025, Solventum reported CapEx of $379.00M, edged down 0.3% below 2024.
Solventum Capital Expenditures 2024: $380.00M
Solventum CapEx in 2024 was $380.00M, surged 31.0% from 2023. This figure represents the highest annual value in the available history.
Solventum Capital Expenditures 2023: $290.00M
2023's CapEx for Solventum came in at $290.00M, grew 15.5% from 2022.
Solventum Capital Expenditures 2022: $251.00M
Solventum posted CapEx of $251.00M in 2022, declined 9.4% below 2021. This figure represents the lowest annual value in the available history.
Solventum Capital Expenditures 2021: $277.00M
Solventum CapEx in 2021 was $277.00M.
See more financial history for Solventum (SOLV).
Sector peers by CapEx
Healthcare peers of Solventum (SOLV), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $5.91B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $5.91B
- $4.83B
- $4.11B
- $3.62B
- $1.86B
- $1.21B
Frequently asked questions
Solventum (SOLV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation